It is important for both good patient care and health care economics to gain the most information possible from each test performed. This is true for the exercise test which provides both diagnostic and prognostic information. 1 This means not only looking at the ST segment response but also accurately reporting and identifying the significance of other exercise parameters including blood pressure (BP).
In this study, we included Minnesota residents who had nonimaging, symptom-limited treadmill exercise tests on the Bruce protocol between ages 30 and 79 years. Where multiple qualifying tests were available for a given patient, the
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METHODS
Our database was reviewed from 1993 to 2010 using the first stress test of a patient. Non-Minnesota residence, baseline cardiovascular (CV) disease, rest DBP <60 or >100 mm Hg, and age <30 or ≥80 were exclusion criteria. DBP response was classified: normal if peak DBP-rest DBP < 0, borderline 0-9, and abnormal ≥10 mm Hg. Mortality was determined from Mayo Clinic records and Minnesota Death Index. Logistic regression was used to determine the relationship of DBP response to the presence of comorbidities. Cox regression was used to determine total and CV mortality risk by DBP response. All analyses were adjusted for age, sex, and resting DBP.
first test chronologically was chosen to maximize follow-up. Patients were excluded if they 1 had documented history of CV disease-including ischemic heart diseases, heart failure, cardiac surgery, structural or valvular heart diseases, major arrhythmias, defibrillator or pacemaker, congenital heart diseases, cerebrovascular diseases, and peripheral vascular diseases 2 ; pre-exercise DBP was <60 or >100 mm Hg.
Clinical data
We collected demographic and clinical data prospectively at the time of the exercise test. Heart rate (HR), BP, and other exercise parameters were uploaded electronically to our database from the GE CASE stress testing systems (Milwaukee, WI). Patient characteristics-including age, sex, and anthropometric data-and comorbidities were collected at the time of the stress test from patient medical charts and patient interview. We specifically looked comorbidities including diabetes and hypertension (defined by the previous diagnosis or receiving antihypertension medication), obesity (defined as body mass index ≥ 30 kg/m 2 ), current smoking, and use of an HR-lowering drug (beta-blocker or nondihydropyridine calcium channel blocker).
Exercise test protocol and variables
Symptom-limited treadmill exercise testing was performed on usual medications using the standard Bruce protocol according to ACC/AHA guidelines. 12, 13 Patients were not allowed to grip the treadmill handrails tightly. Resting HR and BP measurements were obtained in the standing position immediately before the test. BP was measured by auscultation with a stethoscope placed over the brachial artery while the cuff was inflated and deflated manually according to standard methods. DBP was taken as the fifth Korotkoff phase (disappearance of all sound). 14 Symptoms, BP, HR, rating of perceived exertion, and workload were electronically entered into the database during the final minute of each stage of exercise, peak exercise, 1 and 3 minutes of active recovery at 1.7 MPH/0% grade, and 6 minutes postpeak exercise in seated recovery.
Exercise test interpretation data including the reason for termination, symptoms, abnormal signs, and exercise electrocardiographic (ECG) analysis were added to the database immediately after the test. DBP response was classified as normal if peak DBP-rest DBP was <0, borderline if 0-9, and abnormal if ≥10 mm Hg. Functional aerobic capacity was expressed as 100% × actual performance time/ predicted performance time based on previous publications from our laboratory. 10 Peak HR was also expressed as percent predicted peak HR. 15 HR recovery was calculated as peak exercise HR minus HR at 1 minute of active recovery at 1.7 MPH/0% grade. An abnormal exercise ECG was defined as any ST depression or elevation >1.0 mm irrespective of the resting ECG, while an abnormal exercise ECG was considered positive only if the resting ECG did not present with significant ST-T abnormalities, the patient was not taking digitalis, and rate-related left bundle branch block did not occur.
Mortality outcomes
Outcomes were taken from Mayo Clinic patient records and the Minnesota Death Index which was reviewed in March 2016. A death was considered to be CV-related if a CV condition was included among the first three listed causes in the Minnesota Death Index. Mortality data were classified using ICD 9 (391, 391.9, 394-398, 402, 404, 410-414, 415-417, 420-429, 430-438, 440-448, 451-454, 456-459) and ICD 10 (I101, I05-I09, I11, I13, I20-I25, I26-I28, I30-I52,  I60-I69, I70-I79, I80-I89) codes.
Statistical analysis
Statistical analyses were performed using SAS 9.4 (Raleigh, NC). Patient characteristics, outcomes, and exercise data were analyzed by BP groups. Logistic regression was used to determine the relationship of DBP response to the presence of obesity (body mass index ≥ 30 kg/m 2 ), current smoking, hypertension, and diabetes. Cox regression was used to determine long-term total and CV mortality risk according to DBP response. All analyses were adjusted for age, sex, and resting DBP. We also performed fully adjusted Cox regression analyses using hypertension, diabetes, current smoking, and use of an HR-lowering drug as covariates, along with other exercise variables including low functional aerobic capacity (<80% predicted), abnormal HR recovery, and abnormal exercise ECG. P < 0.05 was considered significant for all analyses.
RESULTS

Study population
A total of 20,760 patients (age 51 ± 11 years) were available for analysis. There were 7,314 females (35%). Their demographic and clinical data stratified by DBP response, along with the long-term outcome data are shown in Table 1 .
Exercise test results
Exercise test data by DBP response are provided in part A of the Table 1 . Because of the large sample size, even minor differences, such as in resting HR or highest rating of perceived exertion reached statistical significance, though some age trends were pronounced. In general, patients with normal DBP response (N = 11,254, 54%) have the overall best results, though differences among the groups are generally small. Functional aerobic capacity was the same in normal and borderline DBP groups, but lower in patients with abnormal DBP response. Rest DBP/peak DBP averaged 82 ± 8/69 ± 15 mm Hg in normal vs. 79 ± 9/82 ± 9 mm Hg in borderline vs. 76 ± 9/92 ± 11 mm Hg in abnormal DBP response. Resting DBP was lower in patients with abnormal DBP response, while their peak DBP was higher. Resting SBP was not different between borderline and abnormal DBP groups, but the SBP of abnormal response group was higher with a lower peak HR. Table 1 part B shows the rates of obesity, hypertension, diabetes, and current smoking along with odds ratios (95% confidence intervals) for borderline and abnormal vs. normal DBP response. Patients with borderline and abnormal DBP response had more obesity, hypertension, diabetes and were more likely to be current smokers compared with patients with normal DBP response.
Comorbidities
Outcomes
There were a total of 1,582 deaths (7.6%) over an average follow-up of 12.4 ± 5.0 years. Consistent with the exclusion of baseline CV disease and residence in a state (Minnesota) with low CV mortality, the overall and CV death rates (557, 2.7%) were low. In the Table 1 part C hazard ratios (95% confidence intervals) for death and CV death are shown. Although there was a trend of increasing total and CV death rates with borderline and abnormal DBP response, hazard ratios were not significant after minimal adjustment for age, sex, and pre-exercise DBP or after full adjustment for clinical risk factors and other exercise test abnormalities. Substitution of peak DBP or delta DBP as a continuous variable for the categorical variables normal, borderline, and abnormal DBP response did not identify a significant impact of DBP on CV or total death (data not shown). Continuous variables expressed as mean ± SD; discrete variables N (%). Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure; CV, cardiovascular; FAC, functional aerobic capacity; HR, heart rate; bpm, beats per minute; OR, odds ratio; CI, confidence interval; HR, hazard ratio.
a Different than normal DBP at P < .05. b Borderline DBP different than abnormal DBP at P < .05.
DISCUSSION
We confirm that a decrease in DBP is the normal response to exercise seen in more than 50% of exercise tests. DBP response to exercise is significantly associated with the prevalence of obesity, hypertension, diabetes, and current smoking at the time of the stress test, though the actual differences in rates of these comorbidities among DBP groups are small. A borderline (increase of <10 mm Hg) or abnormal (increase of >10 mm Hg) was not significantly associated in an independent manner with long-term death or CV death. DBP response to exercise is not strongly related to functional aerobic capacity, which has been shown to be the strongest prognostic factor on the exercise test. 16 The physiological basis of the observed interaction between resting DBP and change in DBP with exercise is not clear, but resting DBP was not significant in any of the Cox regression models. This may represent simple regression to the mean.
In a meta-analysis which investigated exercise BP and long-term CV events and mortality-including 12 longitudinal studies with more than 46,000 patients and 15 years follow up-it was determined that hypertensive BP response (systolic BP ≥210 mm Hg for males and ≥190 mm Hg for females) at moderate exercise intensity during exercise stress testing is an independent risk factor for CV events and mortality, but they only examined the SBP response. 8 One other large study of 12,000 patients investigated the relationship of hemodynamic response and cardiometabolic risk factors in patients-including patients with coronary artery disease (CAD)-undergoing treadmill exercise testing. Patients with obesity, hypertension, and smokers showed higher values of peak SBP and DBP, while in diabetic patients they did not find any difference in DBP. In contrast to their findings, we found more abnormal DBP response in patients having these comorbidities. The difference may be explained by the different study populations. 17 In Myers et al. 18 study-which focused on exercise capacity and mortality, both in healthy men and patients with CAD-peak SBP was lower in those who died, while DBP was not different. They stated that exercise capacity is a more powerful predictor of mortality than other exercise test parameters or even risk factors for CV disease. We would also like to emphasize that DBP responses-even with the presence of comorbidities-are not associated with long-term total or CV mortality; therefore focus should be turned to other variables including exercise capacity and HR recovery. 19, 20 In terms of potential mechanisms, an increase in DBP with exercise may be a result of increased arterial stiffness or endothelial dysfunction, which are considered early signs of atherosclerotic vascular disease. 21, 22 On the other hand, the fact that coronary arteries fill during diastole might suggest that an increase in DBP during exercise could be protective in patients with coronary artery disease, and this has been at least somewhat confirmed in the settling of myocardial perfusion imaging. 23 High DBP during exercise may also cause enhanced external counterpulsation, increasing the development of collateral channels. 24 Thus, although we can speculate that increased DBP with exercise signals higher peripheral arteriolar resistance and impaired exercise-induced vasodilation through various mechanisms which increase myocardial oxygen demand during exercise by increasing afterload, higher exercise DBP conversely has the potential to decrease exercise-induced myocardial ischemia by increasing of myocardial blood flow.
Strengths and limitations
The strengths of our study include a large consecutive cohort with complete mortality follow-up over a long time period. Exercise test data were robust and complete, and important data on comorbidities and pharmacotherapies were available.
In terms of limitations, our study reflected the limited racial diversity seen in Minnesota, so our results may not be applicable to more diverse racial or ethnic groups, especially African Americans who have high rates of hypertension in comparison to white Americans. Overall mortality was low, reflecting the status of Minnesota as a state with low total and CV mortality.
Measuring BP on an exercise test is not always easy at a high HR given noise of the treadmill and patient motion. We relied solely on unconfirmed DBP assessment by auscultation with a manually inflated cuff; invasive measures of BP were not performed. Exercise tests were not systematically repeated to determine if the response of DBP to exercise was consistent.
Exercise tests were conducted in a clinical environment, and patients were instructed to exercise to subjective fatigue. Gas exchange was not measured to confirm the level of metabolic effort by the respiratory exchange ratio.
For our nonimaging noncardiopulmonary stress tests, we generally used the Bruce protocol (>90% of tests where gas exchange is not measured), so we did not have a sufficient number of patients of cycle ergometer or treadmill tests on other protocols to perform similar analyses of DBP responses.
